Medibase
EN VI JA

News · Articles

Regulatory news & curated articles

Regulatory updates, official notices, and curated commentary — organised by section: medicines, supplements, foods, medical devices, and cosmetics.

Total articles: 23
All 23 Medicine 13 Supplement 2 Food 3 Medical device 0 Cosmetic 0 General 5
Clear

4 articles. Showing 1–4.

Circular 44/2026/TT-BYT: bioequivalence deadline for registered generics moved to 1 November 2028
Medicine

Circular 44/2026/TT-BYT: bioequivalence deadline for registered generics moved to 1 November 2028

The Ministry of Health has amended Circular 07/2022/TT-BYT. Registered generics that fall under the bioequivalence (BE) requirement now have until 1 November 2028 — not 1 November 2026 — to be published as having BE evidence; after that date they can no longer be made, imported or renewed without it. The circular took effect on 1 November 2026. Separately, the Drug Administration of Vietnam published its batch 4 list for 2026: 45 drugs with proven bioequivalence (Decision 1003/QD-QLD, 9 November 2026).

Circular 45/2026/TT-BYT amends Vietnam's GMP rules: radiopharmaceuticals, investigational drugs and change control — effective 1 January 2027
Medicine

Circular 45/2026/TT-BYT amends Vietnam's GMP rules: radiopharmaceuticals, investigational drugs and change control — effective 1 January 2027

Decision 3044/QD-BYT: Ministry of Health publishes four amended drug registration procedures under Circular 32/2026
Medicine

Decision 3044/QD-BYT: Ministry of Health publishes four amended drug registration procedures under Circular 32/2026

Circular 32/2026/TT-BYT — new drug-registration framework from 1 October 2026
Medicine

Circular 32/2026/TT-BYT — new drug-registration framework from 1 October 2026